Novartis offers $17.7m support in the fight for health equity
Outsourcing Pharma
JUNE 28, 2022
The pharmaceutical company is expanding its alliance with historically Black medical schools to bolster the battle against systemic health disparities.
Outsourcing Pharma
JUNE 28, 2022
The pharmaceutical company is expanding its alliance with historically Black medical schools to bolster the battle against systemic health disparities.
STAT
MARCH 7, 2023
BOSTON — FDA Commissioner Robert Califf said on Monday that it “bothers” him that Novo Nordisk, which makes an obesity medication, funded the development of obesity coursework for medical schools.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
MARCH 6, 2023
… A two-part message is permeating the halls of medicine and the fabric of society, sliding into medical school lectures, pediatrician offices, happy hours, and social feeds: Obesity is a chronic biological disease — and it is treatable with a new class of medications , STAT explains. The
pharmaphorum
OCTOBER 7, 2022
Expert speaking companies include Plexium , Stanford University Medical School, Seed Therapeutics, Janssen Pharmaceutical Companies of Johnson & Johnson, Kymera Therapeutics, Foghorn Therapeutics & many more. View the full event guide here.
The Physician Pharmacist
OCTOBER 27, 2023
The MCAT: Everything You Need To Know How Hard is Medical School Can you work while in Medical School? The Physician Pharmacist Do's and Don'ts 6 Most Common Questions About Transitioning From Pharmacy to Medicine The Art of Applying to Medical School (The Pharmacy Student Edition)!
pharmaphorum
JANUARY 18, 2023
Pharmaceutical companies and biotechs are also adapting their approaches, launching patient finding and engagement programmes that can start years before clinical trials begin and allow them to run ‘recontact by genotype’ studies that the Resilience Project would have liked to do.
European Pharmaceutical Review
SEPTEMBER 2, 2022
She has worked with regulatory agencies and pharmaceutical companies for over 10 years. She also has been conducting fundamental research as an academic in several universities, with her last academic position held at Harvard Medical School. Before that she has been an independent scientific advisor. About the author.
Let's personalize your content